Skip to Content

AbbVie

AbbVie is a publicly traded research-driven biopharmaceutical company that began as a spinoff from Abbott Laboratories in 2013. With a workforce of roughly 47,000, AbbVie prides itself on coming up with new treatments for chronic conditions and life-threatening illnesses, and its drugs are some of the world’s bestsellers, including cancer treatment Imbruvica and Humira, an immunosuppressant used to treat arthritis and Crohn’s disease. In 2016, AbbVie acquired Stemcentrx for $5.8 billion as part of a campaign to bolster its oncology research division. In 2020, AbbVie completed its purchase of Allergan, an Irish drug manufacturer, for $63 billion.
Courtesy of AbbVie
Lists ranking AbbVie
RANK247
Global 500 - 2021Total revenue for the world’s biggest companies fe...READ MOREview in list
RANK99
100 Best Large Workplaces for Millennials - 2021We surveyed tens of thousands of employees to crea...READ MOREview in list
RANK68
Fortune 500 - 2021This year’s Fortune 500 marks the 67th running of ...READ MOREview in list
RANK58
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list
RANK3
20 Best Workplaces in Biotechnology and Pharmaceuticals - 2021The best U.S. biotechnology and pharmaceutical com...READ MOREview in list
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
RANK15
World’s 25 Best Workplaces - 2020Companies on this year's list earned national reco...READ MOREview in list